Document and Entity Information Document Type Entity Registrant Name Entity Filer Category Entity Small Business Entity Emerging Growth Company Entity Central Index Key Amendment Flag INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS Statement [Table] Statement [Table] Statement [Line Items] Statement Assets [Abstract] ASSETS Assets, Current [Abstract] Current Assets: Cash and Cash Equivalents, at Carrying Value Cash and cash equivalents Nontrade Receivables, Current Other accounts receivable Prepaid Expense and Other Assets, Current Prepaid expenses and other current assets Assets, Current Total current assets Assets, Noncurrent [Abstract] Long-Term Assets: Prepaid Expense and Other Assets, Noncurrent Prepaid expenses and other long-term assets Other Assets, Noncurrent Other long-term assets Restricted Cash, Noncurrent Restricted Cash Operating Lease, Right-of-Use Asset Right of use asset (Note 3) Operating lease right of use asset Property, Plant and Equipment, Net Property and Equipment, Net (Note 5) Depreciated cost Property and equipment, net Assets, Noncurrent Total Long-Term Assets Assets Total assets Liabilities and Equity [Abstract] LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT) LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT) Liabilities, Current [Abstract] Current Liabilities: Accounts Payable, Current Accounts payables Accounts payable Accrued Liabilities, Current Accrued expenses Short-Term Debt Short-term loans (Note 6) Short-term loans (Note 11) Operating Lease, Liability, Current Operating lease liability (Note 4) Operating lease liability (Note 3) Employee-related Liabilities, Current Employees related liability Liabilities, Current Total current liabilities Liabilities, Noncurrent [Abstract] Long-Term Liabilities: Operating Lease, Liability, Noncurrent Operating lease liability (Note 4) Operating lease liability (Note 3) Warrants and Rights Outstanding Warrants outstanding Warrants liability (Note 4) Liabilities, Noncurrent Total long-term liabilities Liabilities Total liabilities Stockholders' Equity Attributable to Parent [Abstract] Stockholders' Deficit: Stockholders' Deficit: Common Stock, Value, Issued Common Stock of $0.00005 par value - Authorized: 250,000,000 shares at December 31, 2025 and 100,000,000 shares at December 31, 2024 respectively; Issued and outstanding: 11,034,775 and 6,141,762 shares at December 31, 2025 and December 31, 2024 respectively Common stock $0.00005 par value; 250,000,000 shares authorized and 11,034,775 shares issued and outstanding Additional Paid in Capital, Common Stock Additional paid-in-capital Treasury Stock, Common, Value Treasury stock Treasury stocks Retained Earnings (Accumulated Deficit) Accumulated deficit Accumulated deficit Stockholders' Equity Attributable to Parent Balance Balance Total stockholders' deficit Liabilities and Equity Total liabilities and stockholders' deficit Common Stock, Par or Stated Value Per Share Common stock, par value (in dollars per share) Common Stock, par value (in dollars per share) Common Stock, Shares Authorized Common Stock, shares authorized Common Stock, Shares, Issued Common Stock, shares issued Common Stock, Shares, Outstanding Common Stock, shares outstanding INTERIM CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS Operating Expenses [Abstract] Operating expenses: Research and Development Expense Research and development Research and development, net General and Administrative Expense General and administrative Operating Income (Loss) Operating loss Interest Income (Expense), Nonoperating Financial income (expense), net Financial expense, net Financial income (expense), net Fair Value Adjustment of Warrants Change in fair value of warrant liability Gain on change in fair value of Warrants liability (Note 7) Gain on change in fair value of Warrants liability (Note 7) Net Income (Loss) Attributable to Parent Net loss Net loss Net loss Earnings Per Share, Basic Basic net loss per share (in dollars per share) Earnings Per Share, Diluted Diluted net loss per share (in dollars per share) Weighted Average Number of Shares Outstanding, Basic Weighted average number of shares outstanding used in computing basic net loss per share (in shares) Weighted Average Number of Shares Outstanding, Diluted Weighted average number of shares outstanding used in computing diluted net loss per share (in shares) STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) Equity Components [Axis] Equity Component [Domain] Common Stock [Member] Common Stock Common stock Additional Paid-in Capital [Member] Additional paid-in capital Treasury Stocks [Member] Treasury stocks Accumulated Deficit [Member] Accumulated deficit Accumulated deficit Shares, Outstanding Balance (in shares) Balance (in shares) Stock Issued During Period, Value, Issued for Services Stock-based compensation related to stock granted to service providers Stock Issued During Period, Shares, Issued for Services Stock-based compensation related to stock granted to service providers (in shares) Issuance of common stock Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures Stock-based compensation related to stock and options granted to directors and employees Stock Issued During Period, Shares, Share-based Compensation, Net of Forfeitures Stock-based compensation related to stock and options granted to directors and employees (in shares) Represents the information pertaining to issuance under at the market. Issuance Of Share Value Issuance of shares in at-the-market (ATM) offering, net (Note 4) Issuance of shares in at-the-market (ATM) offering (Note 8) Represents the information pertaining to issuance under at the market. Issuance Of Shares At The Market Issuance of shares in at-the-market (ATM) offering, net (Note 4) (in shares) Issuance of shares in at-the-market (ATM) offering (Note 8) (in shares) Number of shares value for private placement. Issuance of shares for private placement value Issuance of shares for private placement, net (Note 4) Issuance of shares for private placement (Note 8) Number of shares issued for private placement. Issuance of shares for private placement Issuance of shares for private placement, net (Note 4) (in shares) Issuance of shares for private placement (Note 8) (in shares) Value of stock issued during the period as a result of exercise of warrants Stock Issued During Period, Value, Exercise Of Warrants Exercise of warrants (Note 8) Exercise of warrants (Note 4) Number of shares issued during the period as a result of exercise of warrants Stock Issued During Period, Shares, Exercise Of Warrants Exercise of warrants (Note 8) (in shares) Exercise of warrants (Note 4) (in shares) Value of stock issued during the period under a debt for equity swap. Stock Issued During Period, Value, Debt For Equity Swap Debt-for-Equity Swap Number of shares issued during the period under a debt for equity swap. Stock Issued During Period, Shares, Debt For Equity Swap Debt-for-Equity Swap (in Shares) INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Net Cash Provided by (Used in) Operating Activities [Abstract] Cash flows from operating activities: Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Net loss Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Adjustments to reconcile net loss to net cash used in operating activities: Depreciation Depreciation Stock or Unit Option Plan Expense Stock-based compensation related to options granted to employees and directors Increase (Decrease) in Operating Lease Liability Decrease in lease liability Change in operating lease liability Change in operating lease liability, net It represents the increase (decrease) during the reporting period in accounts receivable and prepaid expenses. Increase Decrease In Accounts Receivable and Prepaid Expenses Decrease (increase) in other accounts receivable and prepaid expenses Decrease (increase) in prepaid expenses and other accounts receivable Increase (Decrease) in Accounts Payable Increase in accounts payables The increase (decrease) in the aggregate amount of expenses incurred but not yet paid during the reporting period. Increase (Decrease) in Accrued Expenses Increase in accrued expense Amount of increase (decrease) in the aggregate amount of interest expenses during the reporting period. Increase (Decrease) in Interest Expenses Increase in interest expense Increase (Decrease) in Accrued Liabilities Increase in employees related liability and accrued expenses Increase (decrease) in employees related liability and accrued expenses Net Cash Provided by (Used in) Operating Activities Net cash used in operating activities Net Cash Provided by (Used in) Investing Activities [Abstract] Cash flows from investing activities: Payments to Acquire Property, Plant, and Equipment Purchase of property and equipment Cash Provided by (Used in) Investing Activity, Including Discontinued Operation Total net cash provided by investing activities Net Cash Provided by (Used in) Financing Activities [Abstract] Cash flows from financing activities: Amount of cash inflow from at the market. Proceeds From At The Market Proceeds from issuance of shares in at-the-market (ATM) offering (Note 8) Proceeds from issuance of shares in at-the-market (ATM) offering (Note 4) Proceeds from Issuance of Private Placement Proceeds from Issuance of shares for private placement (Note 4) Proceeds from Issuance of shares for private placement (Note 8) Proceeds from Short-Term Debt Proceeds from short-term loans (Note 6) Proceeds from issuance of notes payable Proceeds from Issuance of Warrants Proceeds from warrants issuance (Note 4) Proceeds from warrants issuance (Note 7) Net Cash Provided by (Used in) Financing Activities Net cash provided by financing activities Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Increase (decrease) in cash and cash equivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Cash, cash equivalents and restricted cash at end of the period Cash, cash equivalents and restricted cash at the beginning of the period Cash balance Non-Cash Activities: The amount of reclassification of warrants liabilities to equity. Reclassification Of Warrants Liabilities To Equity Reclassifying the warrant liability to equity (Note 4) Reclassifying the warrants liabilities to equity (Note 8) GENERAL Business Description and Basis of Presentation [Text Block] GENERAL BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation and Significant Accounting Policies [Text Block] BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES SIGNIFICANT ACCOUNTING POLICIES LEASES Lessee, Operating Leases [Text Block] LEASES STOCKHOLDERS' DEFICIT Stockholders' Equity Note Disclosure [Text Block] STOCKHOLDERS' DEFICIT STOCK CAPITAL FAIR VALUE MEASUREMENT Fair Value Disclosures [Text Block] FAIR VALUE MEASUREMENT SHORT-TERM LOANS Short-Term Debt [Text Block] SHORT-TERM LOANS SEGMENT REPORTING Segment Reporting Disclosure [Text Block] SEGMENT REPORTING SUBSEQUENT EVENTS Subsequent Events [Text Block] SUBSEQUENT EVENTS Disclosure of accounting policy pertaining to unaudited interim financial statements. Unaudited Interim Financial Statements Policy [Policy Text Block] Unaudited Interim Financial Statements Significant Accounting Policies [Text Block] Significant Accounting Policies New Accounting Pronouncements, Policy [Policy Text Block] Recent Accounting Standards Updates Not Yet Effective and Recently Adopted Accounting Pronouncements Recent Accounting Standards Use of Estimates, Policy [Policy Text Block] Use of estimates Lease, Cost [Table Text Block] Schedule of supplemental cash flow and total lease cost information Lessee, Operating Lease, Liability, Maturity [Table Text Block] Schedule of future lease payments under operating leases Share-based Compensation, Stock Options, Activity [Table Text Block] Summary of the Company's option activity Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity [Table Text Block] Schedule of restricted stock activity Tabular disclosure includes the number and weighted-average issue prices for warrants issued to services providers that were outstanding at the beginning and end of the year, and issued during the year. Schedule Stock Awards Activity Related To Service Providers [Table Text Block] Schedule of total stock-based compensation expense Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block] Summary of significant expense categories regularly viewed by CODM Amount of accumulated undistributed earnings (deficits). Retained Earnings (Accumulated Deficits) Accumulated deficit Lessee, Lease, Description [Table] Consolidated Entities [Axis] Consolidated Entities [Domain] Subsidiaries [Member] Representing information pertaining to Brainstorm Cell Therapeutics, Ltd. a wholly-owned subsidiary formed in Israel, which conducts all of the research and development activities of the company. BCT [Member] BCT Lessee, Lease, Description [Line Items] LEASES Area of Land Area of land Lessee, Operating Lease, Term of Contract Term of lease Lessee, Operating Lease, Renewal Term Extension term of lease Sale Leaseback Transaction, Monthly Rental Payments Monthly lease payments The increase (decrease) during the period in the operating lease right of use asset. Increase (Decrease) in Operating Lease Right Of Use Asset Decrease in ROU Operating Lease, Liability Operating lease liability Total lease liability balance Lease, Cost Lease costs Operating Lease, Weighted Average Remaining Lease Term Operating lease, weighted average remaining lease term Operating Lease, Weighted Average Discount Rate, Percent Operating lease, weighted average discount rate percent Operating Lease, Payments Cash payments for operating leases The amount of operating lease expense (income). Operating Lease Expense (Income) Operating lease expense The amount of finance lease expense (income). Finance Lease Expenses (Income) Finance lease expense (income) Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year 2026 Lessee, Operating Lease, Liability, to be Paid, Year One 2026 Lessee, Operating Lease, Liability, to be Paid Total future lease payments Lessee, Operating Lease, Liability, Undiscounted Excess Amount Less imputed interest Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Sale of Stock [Axis] Sale of Stock [Domain] Private Placement [Member] Private Placement This member represents at market offering. At Market Offering [Member] At Market Offering Option Indexed to Issuer's Equity, Type [Axis] Option Indexed to Issuer's Equity, Type [Domain] This member stands for Global Share Option Plan 2014 And US Stock Option And Incentive Plan 2014. Global Share Option Plan 2014 And US Stock Option And Incentive Plan 2014 [Member] Global Share Option Plan 2014 And US Stock Option And Incentive Plan 2014 Award Type [Axis] Equity Award [Domain] Share-Based Payment Arrangement, Option [Member] Employee Stock Option Restricted Stock [Member] Restricted Stock Share-based Compensation Arrangement by Share-based Payment Award [Line Items] STOCK CAPITAL Stockholders' Equity Note, Stock Split, Conversion Ratio Reverse stock split Stock Issued During Period, Value, New Issues Aggregate offering amount Stock Issued During Period, Shares, New Issues Aggregate shares sold The cash inflow before payment of issuance costs, from the additional capital contribution to the entity. Gross Proceeds From Issuance of Common Stock Gross proceeds Payments of Stock Issuance Costs Issuance costs Proceeds from Issuance of Common Stock Net proceeds Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized Shared pool of shares of the Common Stock available for issuance Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized Number of shares authorized Additional extended term, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Additional Extended Term Additional extend the term (in years) Common Stock, Capital Shares Reserved for Future Issuance Future issuance of common stock Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Unrecognized compensation cost Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Weighted average period Stock Repurchased During Period, Shares Shares repurchased Stock Repurchased During Period, Value Value of shares repurchased Share-Based Payment Arrangement, Expense Share-based payments Total stock-based compensation expense Share based compensation expense Warrant [Member] Private placement warrants Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Represents the information pertaining to securities purchase agreement. Securities Purchase Agreement [Member] Securities purchase agreement Represents the information pertaining to public offering. Public Offering [Member] Public offering Class of Warrant or Right [Axis] Class of Warrant or Right [Domain] Represents the information pertaining to the pre funded warrants. Pre Funded Warrants [Member] Pre Funded Warrants Represents the information pertaining to the unregistered warrants. Unregistered Warrants [Member] Unregistered Warrants Represents the information pertaining to July 2023 warrants. July 2023 Warrants [Member] July 2023 warrants Represents information pertaining to common warrants. Common Warrants [Member] Common warrants Subsequent Event Type [Axis] Subsequent Event Type [Domain] Subsequent Event [Member] Subsequent events Class of Warrant or Right, Number of Securities Called by Warrants or Rights Class of Warrant or Right, Number of Securities Called by Warrants or Rights Warrants to purchase shares of common stock Shares Issued, Price Per Share Purchase price per share Share issue price Class of Warrant or Right, Exercise Price of Warrants or Rights Class of Warrant or Rights, Exercise Price of Warrants or Rights Warrants issue price per unit Proceeds from Issuance or Sale of Equity Gross proceeds The period after the issuance date, the warrants become exercisable. Class of Warrant or Right, Exercisable Period After issuance date, warrants become exercisable (in months) Warrants and Rights Outstanding, Term Warrants term Class of Warrant or Right, Exercise price Class of warrant exercise price Number of securities purchase agreement entered to offer securities in an offering to investor. Issue Of Securities, Number Of Purchase Agreement Securities issuance, number of securities purchase agreement Maximum aggregate offering price of securities agreed to be issued under the security purchase agreement. Issue Of Securities, Maximum Aggregate Offering Price Maximum aggregate issuance Number of securities into which the class of warrant or right may be converted expressed as percentage of purchased units. Class of Warrant or Right, Number of Securities Called by Warrants or Rights, Percentage Of Purchased Units Warrant exercisable, percentage of purchased units Class of Warrant or Right, Number of Securities Called by Each Warrant or Right Number of shares issued on exercise of each warrant Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Amount of options, Outstanding at end of period Amount of options, Outstanding at beginning of period Options outstanding at end of period Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross Amount of options, Granted Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Amount of options, Vested Amount of options, Exercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period Amount of options, Forfeited Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number Options exercisable Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Amount of options, Vested at end of period Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Weighted average exercise price, Outstanding at end of period (in dollars per share) Weighted average exercise price, Outstanding at beginning of period (in dollars per share) Exercise price (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Weighted average exercise price, Granted (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Weighted average exercise price, Vested (in dollars per share) Weighted average exercise price, Exercised (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Weighted Average exercise Price, Forfeited (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Weighted average exercise price, Exercisable at end of period (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Weighted average exercise price, Vested at end of period (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number Number of Shares of Restricted Stock, Nonvested at end of period Number of Shares of Restricted Stock, Nonvested at beginning of period Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period Granted Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period Vested Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period Forfeited Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Weighted Average Grant Date Fair Value, Nonvested at end of period Weighted Average Grant Date Fair Value, Nonvested at beginning of period Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Granted Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Vested Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Forfeited Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms Weighted Average Remaining Contractual Term (Years), Nonvested Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table] Income Statement Location [Axis] Income Statement Location [Domain] Research and Development Expense [Member] Research and development General and Administrative Expense [Member] General and administrative Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] STOCK CAPITAL Short-Term Debt [Table] Short-Term Debt, Type [Axis] Short-Term Debt, Type [Domain] Represents information pertaining to convertible promissory note issued on October 31, 2025. Convertible Promissory Note Issued On October 31, 2025 [Member] Convertible promissory note, October 31, 2025 Represents information pertaining to convertible promissory note issued on November 10, 2025. Convertible Promissory Note Issued On November 10, 2025 [Member] Convertible promissory note, November 10, 2025 Represents information pertaining to convertible promissory note issued on November 20, 2025. Convertible Promissory Note Issued On November 20, 2025 [Member] Convertible promissory note, November 20, 2025 Represents information pertaining to short term loan agreement. Loan agreement Convertible Notes Payable [Member] Unsecured promissory note Statistical Measurement [Axis] Statistical Measurement [Domain] Minimum [Member] Minimum Maximum [Member] Maximum Short-Term Debt [Line Items] SHORT-TERM LOANS Debt Instrument, Face Amount Principal amount Debt Instrument, Unamortized Discount, Current Issued discount Debt Instrument, Fee Amount Legal fees and due diligence fees The maximum percentage of a company's outstanding shares that a holder of a convertible debt instrument is allowed to beneficially own after conversion. Debt Instrument, Convertible, Beneficial Ownership Limitation, Percentage Beneficial ownership limitation, percentage Number of installments within which the company has to be make repayments under debt agreement. Debt Instrument, Number Of Installments Number of installments Debt Instrument, Periodic Payment, Principal Debt instrument periodic payment principal Percentage points added to the reference rate to compute the variable rate on the debt instrument. Debt Instrument, Convertible, Conversion Price Determination, Percentage Discount Applied on Lowest Trading Price Debt instrument conversion on discount applied on lowest trading price percentage Threshold trading days used to determine the lowest stock price for calculating the conversion price. Debt Instrument, Convertible, Conversion Price Determination, Threshold Period Of Trading Days Trading days prior to the conversion Debt Instrument, Interest Rate, Stated Percentage Interest rate percentage Contractual interest rate Contractual interest rate for funds borrowed, under the debt agreement applicable in the event of default. Debt Instrument, Default Interest Rate, Percentage Interest rate increases, percentage Amount of short-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in first month following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). Short-Term Debt, Maturity, Repayments In One Month Repayments of short-term debt maturity in one month Amount of short-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second month following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). Short-Term Debt, Maturity, Repayments In Two Months Repayments of short-term debt maturity in two months Amount of short-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third month following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). Short-Term Debt, Maturity, Repayments In Three Months Repayments of short-term debt maturity in three months Amount of short-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth month following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). Short-Term Debt, Maturity, Repayments In Four Months Repayments of short-term debt maturity in four months Amount of short-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth month following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). Short-Term Debt, Maturity, Repayments In Five Months Repayments of short-term debt maturity in five months Amount of short-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in sixth month following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). Short-Term Debt, Maturity, Repayments In Six Months Repayments of short-term debt maturity in six months Amount of short-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in seventh month following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). Short-Term Debt, Maturity, Repayments In Seven Months Repayments of short-term debt maturity in seven months Amount of short-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in eighth month following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). Short-Term Debt, Maturity, Repayments In Eight Months Repayments of short-term debt maturity in eight months Amount of short-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in ninth month following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). Short-Term Debt, Maturity, Repayments In Nine Months Repayments of short-term debt maturity in nine months Amount of short-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in tenth month following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). Short-Term Debt, Maturity, Repayments In Ten Months Repayments of short-term debt maturity in ten months Number of days from the debt issue date until the first scheduled installment payment is due under the debt instrument. Debt Instrument, Initial Installment Due Initial installment due for debt instrument Number of days between each consecutive scheduled installment payment under the debt instrument following the initial deferral period. Debt Instrument, Subsequent Installment Interval Subsequent installment interval for debt instrument Period following the initial installment deferral period, during which scheduled debt payments are required under the debt instrument. Debt Instrument, Subsequent Monthly Installment Periods Subsequent monthly installment periods for debt instrument Number of securities purchase agreement entered to issue debt instrument to each investors. Debt Instrument, Number Of Purchase Agreement To Each Investor Debt issuance, number of securities purchase agreement Number of debt instruments issued to each investor. Debt Instrument, Number Of Instruments Issued To Each Investor Number of instruments issued Number of accredited investors to whom each debt instruments were issued. Debt Instrument, Number Of Accredited Investors For Each Instrument Number of accredited investors Maximum additional borrowing capacity under a debt instrument. Debt Instrument, Maximum Additional Borrowing Capacity, Amount Maximum additional borrowing capacity Number of installments required to repay the debt amount. Debt Instrument, Repayments, Number Of Installments Number of installments Optional period at specified discounts given to the borrower for early repayment of debt. Debt Instrument, Optional Prepayment Period Optional repayment period Interest rate as percentage of outstanding obligations for funds borrowed in the event of default. Debt Instrument, Debt Default, Interest Rate As Percentage Of Outstanding Obligations Interest rate in event of default Percentage discount applied on lowest trading price in determination of conversion price of convertible debt instrument in the event of default. Debt Instrument, Debt Default, Conversion Price Determination, Percentage Discount Applied On Lowest Trading Price Debt default conversion, discount on lowest trading price Threshold number of trading days as look back period considered in determination of conversion price of convertible debt instrument in the event of default. Debt Instrument, Debt Default, Conversion Price Determination, Threshold Look Back Period Of Trading Days Debt default conversion, look back period Percentage of potential payments in the event of default to be made by the issuer of debt instrument. Debt Instrument, Debt Default, Potential Payment, Percentage Debt default, percentage of potential payment Debt Instrument, Term Term Period during which the issuer is not required to make any scheduled repayments of the debt instruments. Debt Instrument, Non-Amortization Period Non-amortization period Percentage discount applied on trading price in determination of conversion price of convertible debt instrument. Debt Instrument, Convertible, Conversion Price Determination, Percentage Discount Applied On Trading Price Debt conversion, discount on trading price The eligibility period for conversion of convertible debt instrument. Debt Instrument, Convertible, Conversion Eligibility Period Conversion eligibility period The percentage of proceeds from future financings that a lender is entitled (or required) to receive or have applied toward repayment of a debt instrument. Debt Instrument, Lender Right To Claim On Future Financing, Percentage Right to sweep, percentage The minimum amount of proceeds from a future financing that must be raised for the lender's right to claim a specified percentage of the proceeds to apply toward repayment of the debt instrument to be triggered. Debt Instrument, Lender Right To Claim On Future Financing, Threshold Proceed Amount Threshold proceeds to trigger right Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table] Segments [Axis] Segments [Domain] Represents information pertaining to single reportable segment. Single Reportable Segment [Member] Single reportable segment Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items] SEGMENT REPORTING Number of Reportable Segments Number of reportable segment Research and Development Expense [Abstract] Research and Development expenses: Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit incurred under research and development. Research and Development, Labor and Related Expense Payroll and payroll related Amount of fees paid to subcontractors and consultants under research and development. Research and Development, Subcontractors and Consultants Subcontractors and consultants Other Research and Development Expense Other General and Administrative Expense [Abstract] General and Administrative expenses Labor and Related Expense Payroll and payroll related Professional Fees Professional services Other General and Administrative Expense Other Segment Reporting Information, Additional Information [Abstract] Other segment items: The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation. Depreciations Depreciation Subsequent Event [Table] Subsequent Event [Line Items] SUBSEQUENT EVENTS Aggregate offering price of securities agreed to be issued under the security purchase agreement. Issue Of Securities, Aggregate Offering Price Aggregate gross proceeds Increase (Decrease) in Accounts Payable, Trade Increase (decrease) in trade payables Amount of gain (loss) on change in fair value of warrant. Gain Loss On Change In Fair Value Of Warrant Gain on change in fair value of warrants (Note 7) The amount of cash inflow on settlement of debt through issuance of equity on a debt for equity swap plan. Proceeds From Issuance of Shares on Settlement Of Debt Debt-for-Equity Swap RESEARCH AND LICENSE AGREEMENT The entire disclosure on research and license agreement entered by the entity. Research and License Agreement [Text Block] RESEARCH AND LICENSE AGREEMENT PROPERTY AND EQUIPMENT Property, Plant and Equipment Disclosure [Text Block] PROPERTY AND EQUIPMENT COMMITMENTS AND CONTINGENCIES Commitments and Contingencies Disclosure [Text Block] COMMITMENTS AND CONTINGENCIES WARRANTS LIABILITY The entire disclosure of warrants liability. Warrants Liability Disclosure [Text Block] WARRANTS LIABILITY TAXES ON INCOME Income Tax Disclosure [Text Block] TAXES ON INCOME TRANSACTIONS WITH RELATED PARTIES Related Party Transactions Disclosure [Text Block] TRANSACTIONS WITH RELATED PARTIES Basis of Accounting, Policy [Policy Text Block] Basis of presentation Foreign Currency Transactions and Translations Policy [Policy Text Block] Financial statements in U.S. dollars Consolidation, Policy [Policy Text Block] Principles of consolidation Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block] Cash and cash equivalents and restricted cash Property, Plant and Equipment, Policy [Policy Text Block] Property and equipment Disclosure of accounting policy for severance Pay. Severance Pay Policy [Policy Text Block] Accrued post-employment benefit Fair Value of Financial Instruments, Policy [Policy Text Block] Fair value of financial instruments Share-Based Payment Arrangement [Policy Text Block] Accounting for stock-based compensation Earnings Per Share, Policy [Policy Text Block] Basic and diluted net loss per share Income Tax, Policy [Policy Text Block] Income taxes Lessee, Leases [Policy Text Block] Lease accounting Disclosure of accounting policy for treasury stock. Treasury Stock Policy [Policy Text Block] Treasury Stock Commitments and Contingencies, Policy [Policy Text Block] Commitments and Contingencies Tabular disclosure of depreciation rates for property, plant and equipment over the estimated useful lives. Schedule Of Depreciation Rates For Property Plant And Equipment [Table Text Block] Schedule of annual depreciation rates Property, Plant and Equipment [Table Text Block] Schedule of property and equipment Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block] Schedule of options outstanding have been separated into exercise prices Fair Value Measurement Inputs and Valuation Techniques [Table Text Block] Schedule of assumptions used to determine fair value of July 2023 warrants Schedule of Deferred Tax Assets and Liabilities [Table Text Block] Schedule significant components of the Company's deferred tax assets Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block] Schedule of loss from continuing operations, before taxes on income Property, Plant and Equipment [Table] Long-Lived Tangible Asset [Axis] Long-Lived Tangible Asset [Domain] Office Equipment [Member] Office furniture and equipment Computer Equipment [Member] Computer software and electronic equipment Represents information pertaining to laboratory equipment. Laboratory Equipment [Member] Laboratory equipment Property, Plant and Equipment [Line Items] Property, Plant and Equipment Property and equipment The depreciation rate recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation. Property Plant and Equipment Depreciation Rates Property and equipment depreciation rates Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay Amount of severance pay equal to monthly deposits Represents the percentage of all net sales royalty that the company will pay if the making, producing, manufacturing, using, marketing, selling, importing or exporting of such licensed product is covered by a valid claim or is covered by orphan drug status. Percentage of Royalty Payment if Licensed Product Covered by Valid Claim or Orphan Drug Status Percentage of royalty payment if licensed product covered by valid claim or orphan drug status Represents the percentage of all net sales royalty that the company will pay if the making, producing, manufacturing, using, marketing, selling, importing or exporting of such licensed product is not covered by a valid claim or is not covered by orphan drug status. Percentage of Royalty Payment If Licensed Product Not Covered by Valid Claim or Orphan Drug Status Percentage of royalty payment if licensed product not covered by valid claim or orphan drug status This element represents the validity of the royalties' payments by the company not covered by a Valid Claim or Orphan Drug Status in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Validity of Royalty Payment Not Covered by Valid Claim or Orphan Drug Status Validity of royalty payment not covered by valid claim or orphan drug status Leasehold improvements Property, Plant and Equipment, Net [Abstract] Composition: Property, Plant and Equipment, Gross Cost Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Accumulated depreciation Loss Contingencies [Table] Legal Entity [Axis] Entity [Domain] Represents information pertaining to Israel innovation authorities. Israel Innovation Authorities [Member] Israel Innovation Authorities Loss Contingencies [Line Items] COMMITMENTS AND CONTINGENCIES The percentage of royalty payments obligated to be paid as per the agreement for grants received for participation in research Percentage Of Royalty Payments Agreed For Grants Percentage of royalty payments agreed for grants The underlying basis on which the grants are linked. Grants Underlying Basis Grants underlying basis The cash inflow from grants received during the period. Amounts Of Grants Received Amounts of grants received Class of Warrant or Right [Table] Class of Warrant or Right [Line Items] WARRANTS LIABILITY The cash inflow associated with the amount received from issuance of common stock and from holders exercising their stock warrants. Proceeds from Issuance of Common Stock and Warrants Exercises Gross proceeds Liabilities, Fair Value Disclosure Fair value of warrants Share-based Compensation Compensation expense Total stock-based compensation expense Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table] Exercise Price Range [Axis] Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Domain] Represents information pertaining to exercise price $11.25. Exercise Price 11.25 [Member] Exercise Price 11.25 Represents information pertaining to exercise price $25.95. Exercise Price 25.95 [Member] Exercise Price 25.95 Represents information pertaining to exercise price $36.75. Exercise Price 36.75 [Member] Exercise Price 36.75 Represents information pertaining to exercise price $45.60. Exercise Price 45.60 [Member] Exercise Price 45.60 Represents information pertaining to exercise price $61.35. Exercise Price 61.35 [Member] Exercise Price 61.35 Represents information pertaining to exercise price $142.65. Exercise Price 142.65 [Member] Exercise Price 142.65 Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items] STOCK CAPITAL Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Weighted average remaining contractual Life - Years Fair Value Measurement Inputs and Valuation Techniques [Table] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Domain] Fair Value, Inputs, Level 3 [Member] Level 3 Measurement Input Type [Axis] Measurement Input Type [Domain] Measurement Input, Maturity [Member] Time to expiration Measurement Input, Share Price [Member] Common stock price Measurement Input, Risk Free Interest Rate [Member] Risk-free interest rate Measurement Input, Price Volatility [Member] Volatility Fair Value Measurement Inputs and Valuation Techniques [Line Items] FAIR VALUE MEASUREMENT Warrants and Rights Outstanding, Measurement Input Warrants liabilities, inputs Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Share Value, Amount, Noncurrent Warrants liability Tax Credit Carryforward [Table] Income Tax Authority [Axis] Income Tax Authority [Domain] Foreign Tax Authority [Member] Israel Domestic Tax Authority [Member] U.S. Tax Credit Carryforward [Line Items] TAXES ON INCOME Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent Corporate tax rate Deferred Tax Assets, Valuation Allowance Valuation allowance Deferred tax assets, valuation allowance Tax Credit Carryforward, Amount Accumulated tax loss carryforward Operating Loss Carryforwards Operating loss carryforward Deferred Tax Assets, Gross Net deferred tax asset before valuation allowance Deferred Tax Assets, Net of Valuation Allowance Net deferred tax asset Income (Loss) from Continuing Operations before Income Taxes, Domestic United States Income (Loss) from Continuing Operations before Income Taxes, Foreign Israel Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Loss from continuing operations, before taxes on income